Introduction
Ten papers on the treatment of non-specific urethritis have been published in the British Journal of Venereal Diseases since 1971. In view of the epidemiological importance of this condition and the present world-wide interest in it, these papers are reviewed; they are dealt with in chronological order.
The first, by Lassus et al. (1971) , can be dismissed because no control group was invblved, the assessment time was too soon after the initial treatment, and the experiment was not rigorous. (Table II) and 37 (27-7 %) of those with non-specific urethritis (Table III) completed only one week's surveillance.' In fact it is not 'a further' 23 and 37, for these figures include 5 and 12 respectively. Furthermore, for 37 read 31. To their credit the authors did refrain from writing until they could complete a long-term assessment at the end of a 12-month period of surveillance (p. 124). This longterm-230 assessment shows a success-rate of 88.8%. When it is remembered that this length of time favours both reinfection and relapse (but also, of course, spontaneous remission) this is an impressive figure and renders highly questionable all the lengthier regimens that have remained popular.
The investigation by Bhattacharyya and Morton (1973) is, it is to be feared, no evidence of anything. The 191 patients in the four-day oxytetracycline group with which 107 patients in the 21-day Deteclo treated group were compared 'were found to match the study group in all respects except past history; their incidence of NSU was only half that of the present study group' (p. 522). This debonair dismissal of a staggering difference renders doubtful the seriousness of that investigation.
The work by Ford and Smith (1974) referred to one single patient, and accordingly is of little concern. Grimble and Amarasuriya (1975) experimented with a number of treatment regimens. Their two most important findings were that: 'the use of the drug for three weeks by us in a few cases did not result in an increased success (see Table I , footnote)' (p. 200), and the placebo cure-rate was easily the lowest. But these findings too are vitiated by the fact that two weeks only was the time allowed for 'cure' (except in the case of the 21-day oxytetracycline treatment). The purpose of the trial done by Perera (1975) was to compare sustained-release oral tetracycline with encapsulated non-sustained-release oxytetracycline, the treatment in each case lasting for five days. The results are hardly startling, and are not germane to the subject.
In the study by Helmy and Fowler (1975) four treatments were described: (1) tetracycline (500 mg) four times a day for seven days, (2) tetracycline (250 mg) four times a day for 14 days, (3) Deteclo (300 mg) three times a day for 21 days, and (4) oxytetracycline (250 mg) four times a day for four days.
The failure rate (at 21 days except in the case of Deteclo, for which it was at 28 days) ranged only from 19-1 % to 24-0% (population ranges:
131-274). The recurrence rate ranged from 2-2% in (3) treatment to 8 4 % in (2) treatment. Since, however, the method of counting cases of recurrence was not specified, we can draw no firm conclusion from these results. That drawn by the authors was that 'traditional' low-quantity short treatment was not inferior to other forms of treatment.
The article by Prentice et al. (1976) was partly concerned with the aetiology of non-specific urethritis. As regards treatment, it compared mino-231 cycline with a placebo, the treatment lasting six days. 'The interval between taking specimens was on average 8-5 days (range 7-21)' (p. 270).
Finally, in the study by Evans (1977) the results were compared of seven-day treatments with (1) oxytetracycline (250 mg) twice daily, (2) Deteclo (one tablet) twice daily, and (3) Sustamycin (one tablet) twice daily. The noteworthy features of the study were that: the doses were smaller than in other studies-although the results were similar to those associated with larger doses and prolonged treatments, and (p. 42) the author stated that the follow-up period should be greater than three months.
Conclusions
There are five points which emerge from examination of these papers.
1. There is in some of these studies a semblance of experimental rigour, but it is only a semblance. Masterton and Schofield (1972) was not once referred to in the subsequent literature, although it had two outstanding features not to be found elsewhere: it investigated a single-dose oral treatment which looks as though it may be the most effective of all the tetracycline treatments (the high cost per gram of the product can hardly be a serious argument in favour of the universal silence with which this study has been received), and it alone, apart from the recent article by Evans (1977) , talked seriously of a 12-month follow-up. 5. The one long-term study (Masterton and Schofield, 1972) did not use as an element in its comparison a placebo-regimen. That may be the most interesting comparison of them all.
